丹娜生物
(920009)
| 流通市值：3.59亿 | | | 总市值：27.59亿 |
| 流通股本：1008.00万 | | | 总股本：7754.60万 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 211,870,984.52 | 183,672,201.81 | 344,188,296.87 | - |
| 交易性金融资产 | 220,239,079.53 | 222,109,704.58 | 62,026,551.67 | - |
| 应收票据及应收账款 | 8,324,020.1 | 11,166,778.86 | 8,971,247.96 | - |
| 应收账款 | 8,324,020.1 | 11,166,778.86 | 8,971,247.96 | - |
| 预付款项 | 12,437,376.35 | 9,635,372.75 | 8,653,050.01 | - |
| 其他应收款合计 | 181,418.97 | 241,319.63 | 206,721.4 | - |
| 存货 | 30,878,978.65 | 28,036,490.4 | 27,535,430.44 | - |
| 一年内到期的非流动资产 | 64,488,555.56 | 107,790,638.89 | 107,043,138.89 | - |
| 其他流动资产 | 1,030,661.12 | 137,824.63 | 379,612.8 | - |
| 流动资产平衡项目 | 0 | 0 | 0 | - |
| 流动资产合计 | 549,451,074.8 | 562,790,331.55 | 559,004,050.04 | - |
| 非流动资产: | | | | |
| 债权投资 | 102,306,819.44 | 101,771,541.67 | 101,281,819.45 | - |
| 固定资产 | 51,957,406.75 | 52,726,479.96 | 53,299,160 | - |
| 在建工程 | 18,196,281.38 | 5,402,602.41 | 5,080,725.35 | - |
| 使用权资产 | 1,544,726.58 | 1,866,478.41 | 2,189,613.46 | - |
| 无形资产 | 12,341,776.19 | 12,427,470.89 | 12,178,165.59 | - |
| 长期待摊费用 | 5,344,554 | 5,715,657.38 | 5,930,842.46 | - |
| 递延所得税资产 | 3,224,029.44 | 4,198,787.79 | 4,451,309.67 | - |
| 其他非流动资产 | 866,762 | 655,461 | 503,961 | - |
| 非流动资产平衡项目 | 0 | 0 | 0 | - |
| 非流动资产合计 | 195,782,355.78 | 184,764,479.51 | 184,915,596.98 | - |
| 资产平衡项目 | 0 | 0 | 0 | - |
| 资产总计 | 745,233,430.58 | 747,554,811.06 | 743,919,647.02 | 592,796,100 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 3,936,051.01 | 3,796,820.44 | 4,442,003.9 | - |
| 应付账款 | 3,936,051.01 | 3,796,820.44 | 4,442,003.9 | - |
| 合同负债 | 22,298,189.09 | 24,058,594.35 | 25,736,486.64 | - |
| 应付职工薪酬 | 10,957,013.9 | 6,383,333.06 | 14,487,937.03 | - |
| 应交税费 | 2,608,665.33 | 4,338,098.35 | 8,006,278.48 | - |
| 其他应付款合计 | 974,149.39 | 712,700.51 | 820,381.08 | - |
| 一年内到期的非流动负债 | 1,410,627.35 | 1,394,972.62 | 1,402,693.89 | - |
| 其他流动负债 | 613,600.15 | 545,507.53 | 658,476.02 | - |
| 流动负债平衡项目 | 0 | 0 | 0 | - |
| 流动负债合计 | 42,798,296.22 | 41,230,026.86 | 55,554,257.04 | - |
| 非流动负债: | | | | |
| 租赁负债 | 360,033.71 | 742,838.81 | 1,066,099.15 | - |
| 预计负债 | - | 3,320,388.26 | 3,320,388.26 | - |
| 递延收益 | 3,706,350.74 | 3,872,411.26 | 4,059,536.66 | - |
| 递延所得税负债 | 2,194,946.16 | 2,238,154.24 | 2,222,667.15 | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | - |
| 非流动负债合计 | 6,261,330.61 | 10,173,792.57 | 10,668,691.22 | - |
| 负债平衡项目 | 0 | 0 | 0 | - |
| 负债合计 | 49,059,626.83 | 51,403,819.43 | 66,222,948.26 | 57,034,800 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 77,546,000 | 55,390,000 | 55,390,000 | - |
| 资本公积 | 203,039,766.8 | 225,062,991.69 | 224,930,216.58 | - |
| 盈余公积 | 27,695,000 | 27,695,000 | 27,695,000 | - |
| 未分配利润 | 387,893,036.95 | 388,002,999.94 | 369,681,482.18 | - |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | - |
| 归属于母公司股东权益合计 | 696,173,803.75 | 696,150,991.63 | 677,696,698.76 | 535,761,300 |
| 股东权益平衡项目 | 0 | 0 | 0 | - |
| 股东权益合计 | 696,173,803.75 | 696,150,991.63 | 677,696,698.76 | - |
| 负债和股东权益合计 | 745,233,430.58 | 747,554,811.06 | 743,919,647.02 | - |
| 公告日期 | 2026-08-24 | 2026-04-29 | 2026-04-08 | 2025-10-20 |
| 审计意见(境内) | | | 标准无保留意见 | |